Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System

Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System

Bibliográfalaš dieđut
Váldodahkkit:	Balendra, R, Jones, A, Turner, M, Leigh, N, Al-Chalabi, A, Grp, M
Materiálatiipa:	Journal article
Almmustuhtton:	2013

Geahča maid

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
Dahkki: Jones, A, et al.
Almmustuhtton: (2013)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
Dahkki: Balendra, R, et al.
Almmustuhtton: (2015)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
Dahkki: Balendra, R, et al.
Almmustuhtton: (2015)

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
Dahkki: Balendra, R, et al.
Almmustuhtton: (2014)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
Dahkki: Jones, A, et al.
Almmustuhtton: (2014)

A proposed staging system for amyotrophic lateral sclerosis.
Dahkki: Roche, J, et al.
Almmustuhtton: (2012)

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2002)

Biomarkers in amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2009)

REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis
Dahkki: Turner, M, et al.
Almmustuhtton: (2020)

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease
Dahkki: Rutter-Locher, Z, et al.
Almmustuhtton: (2016)

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2007)

Young-onset amyotrophic lateral sclerosis: Historical and other observations
Dahkki: Turner, M, et al.
Almmustuhtton: (2012)

Young-onset amyotrophic lateral sclerosis: historical and other observations.
Dahkki: Turner, M, et al.
Almmustuhtton: (2012)

Quantifying disease progression in amyotrophic lateral sclerosis.
Dahkki: Simon, N, et al.
Almmustuhtton: (2014)

Evolution of white matter damage in amyotrophic lateral sclerosis
Dahkki: Gabel, M, et al.
Almmustuhtton: (2020)

Amyotrophic lateral sclerosis and cerebellum
Dahkki: Renata Kabiljo, et al.
Almmustuhtton: (2022-07-01)

Amyotrophic lateral sclerosis
Dahkki: Leigh P Nigel, et al.
Almmustuhtton: (2009-02-01)

Amyotrophic lateral sclerosis.
Dahkki: Kiernan, M, et al.
Almmustuhtton: (2011)

The reunification of amyotrophic lateral sclerosis
Dahkki: Turner, M
Almmustuhtton: (2018)

Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2011)

Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.
Dahkki: Fang, F, et al.
Almmustuhtton: (2013)

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
Dahkki: Abrahams, S, et al.
Almmustuhtton: (1997)

Neuroimaging in amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2012)

Evolution of white matter damage in amyotrophic lateral sclerosis
Dahkki: Matt C. Gabel, et al.
Almmustuhtton: (2020-05-01)

Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.
Dahkki: Johnston, C, et al.
Almmustuhtton: (2006)

Neuroimaging endpoints in amyotrophic lateral sclerosis
Dahkki: Menke, R, et al.
Almmustuhtton: (2016)

Staging model for amyotrophic lateral sclerosis in Singapore
Dahkki: Yuan Teck Tay, et al.
Almmustuhtton: (2022-07-01)

Advances in the application of MRI to amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2010)

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
Dahkki: Al-Chalabi, A, et al.
Almmustuhtton: (2003)

Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.
Dahkki: Scott, K, et al.
Almmustuhtton: (2009)

Untangling neuroinflammation in amyotrophic lateral sclerosis
Dahkki: Thompson, AG, et al.
Almmustuhtton: (2019)

The sex ratio in amyotrophic lateral sclerosis: A population based study.
Dahkki: Manjaly, Z, et al.
Almmustuhtton: (2010)

Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis
Dahkki: Yildiz, O, et al.
Almmustuhtton: (2025)

Sweet food preference in amyotrophic lateral sclerosis
Dahkki: Turner, M, et al.
Almmustuhtton: (2017)

The tough body at the epicentre of amyotrophic lateral sclerosis
Dahkki: Turner, M, et al.
Almmustuhtton: (2017)

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
Dahkki: Kelly, M, et al.
Almmustuhtton: (2020)

Defining pre-symptomatic amyotrophic lateral sclerosis
Dahkki: Benatar, M, et al.
Almmustuhtton: (2019)

Imaging cerebral activity in amyotrophic lateral sclerosis
Dahkki: Proudfoot, M, et al.
Almmustuhtton: (2019)

CSF chitinase proteins in amyotrophic lateral sclerosis
Dahkki: Thompson, A, et al.
Almmustuhtton: (2019)

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
Dahkki: Bowser, R, et al.
Almmustuhtton: (2011)